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Abstract This article discusses the role of complementary
and alternative medicine (CAM) in the management of
fibroids and associated symptomatology. Since there is such
a paucity of direct research related to fibroids, conditions that
are implicated in the causation of uterine fibroids and symp-
tomatology that CAM treatments may or have been shown to
make a difference are also considered.
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Introduction
Uterine fibroids are a common condition affecting women in
their reproductive and post-reproductive years, with an esti-
mated lifetime incidence of 50% in white women and 80% in
black women.
Complementary and alternative medicine (CAM) is broad-
ly defined as systems of medicine that fall outside of main-
stream care and are external to the politically dominant health
system practices [1]. In this definition, both complementary
and alternative medicines are used interchangeably.
The National Centre for Complementary and Integrative
Health (NCCIH) expands this definition, stating that ‘comple-
mentary medicine is used together with conventional medi-
cine and alternative medicine is used in place of conventional
medicine’ [2]. The boundaries between CAMand convention-
al medicine are not absolute, and specific CAM practices may,
over time, become widely accepted. To confuse the matter
further, certain therapies that are considered as CAM in the
West are part of conventional medicine in the East. For exam-
ple, acupuncture and Chinese herbal medicine are part of the
conventional medical system in China. For purposes of this
article, we will discuss only those therapies that are CAM as
defined in the West.
Recent data shows that patient choice is integrative in that
they are more likely to use both conventional medicine and
CAM. Women are more likely to use CAM than men [3].
CAM use is generally greater in white and middle-class wom-
enwith a higher education compared to black women or wom-
en living in areas of depravity [4].
A trial of 150,000 men and women registered with a Dutch
health insurer reported that those who used integrated CAM/
conventional clinic services are more likely to live longer.
Interestingly, the health care cost to the integrated clinics
was lower than non-integrated clinics, suggesting a role for
an integrated service model in the prevention of long-term
health problems [5].
Aetiopathogenesis Related to CAM
Diet
Dietary therapy is one of the top motivations a woman has for
visiting a CAM practitioner [6].
The incidence of uterine fibroids has been shown to be
greater in populations who consume more red meats such as
beef and ham and alcohol. Women who drink a beer a day or
more increase the risk of developing uterine fibroids by more
than 50 % [7]. On the other hand, dairy consumption appears
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to reduce the risk of fibroids, thus suggesting a role for calcium,
magnesium and phosphorus in the pathogenesis of fibroids;
both calcium and butyric acid inhibit cell proliferation [8].
A diet low in fruits and vegetables has been associated with
an increased risk of developing fibroids [9]. Moreover, wom-
en who consume more citrus fruits are less likely to develop
fibroids, possibly due to the anti-proliferative effect of
flavonoids [9].
Isoflavones
Isoflavones are a branch of flavanoids and are mostly pro-
duced by the monophyletic family, Fabaceae, to which
Chinese herbal medicine (CHM) such as Puerariae Lobata
Radix (Gegen), and foods such as soyabeans, and other
legumes belong. Isoflavone consumption differs; in the
West, 2 mg per day is usual [10]. In the East, up to
50 mg per day can be consumed [11]. There is also a sig-
nificant difference between herb and food isoflavone con-
tent. The main dietary source of isoflavones is soyabean;
one half a cup will yield around 47 mg of isoflavones [12].
The yield from Radix Paeoniae Rubra (Chi Shao) however
is about 30 times higher [12].
Isoflavones contain very small amounts of phytoestrogens
that are weakly estrogenic compounds. Moreover, they are
both estrogenic and anti-estrogenic depending on cell type
and also have anti-oxidant properties, and perhaps, this may
explain why they have not been shown to have an association
or causation with uterine fibroids [13].
The flavones apigenin and luteolin can induce inhibition of
uterine fibroid growth by promoting apoptosis, and quercetin,
the main fruit flavonoid and anti-oxidant, also displays pro-
apoptic effect on tumour cells [14, 15]. The ability of querce-
tin to prevent growths in human cancer cell lines with virtually
no side effects to normal cells has made it an attractive candi-
date for further investigation [16].
Vitamin D is associated with uterine fibroids and is obtain-
ed through diet and sun exposure. Dietary sources of vitamin
D include fatty fish like salmon and tuna and fortified milk.
The recommended daily allowance is 20 ng/ml (600 IU) of
vitamin D a day for people under 70 and over 12 months [17].
In rats, high doses of vitamin D3 shrank uterine fibroids by as
much as 75 %, suggesting a role for vitamin D3. Although the
doses were comparatively much larger than the recommended
daily intake for humans, they were still within the limits con-
sidered safe [18].
Serum vitamin D levels have been correlated with fibroid
size; deficiency correlated with the largest fibroids, whereas
the highest serum vitamin D levels correlatedwith the smallest
fibroids. Total fibroid volume correlated inversely with
vitamin D in African American women. An inverse
correlation was also observed in Caucasians but was
not significant [19••].
Vitamin A has also been investigated, and a dose-
dependent relationship was observed between vitamin A and
the formation of uterine fibroids [20]. Animal sources of vita-
min A appear to be primarily responsible and not sources
derived from fruit or vegetables [9]. The anti-oxidant proper-
ties of vitamins C and E have not shown any association
however [9].
Stress
Stress is a threat to homeostasis. Chronic life stress is
characterised by reward eating (consumption of high-energy
dense and palatable foods), elevation of cortisol, and long-
term weight gain correlates with the incidence of uterine
fibroids [21–24].
Increases in cortisol and insulin may be a natural somatic
protective response to stress, wherein the stress response both
causes and is caused by a threat to homeostasis; i.e. the mech-
anistic trail may be convoluted. For example, stress increases
activities associated with pleasure such as reward eating in
order to inhibit the hypothalamic-pituitary-adrenal axis
(HPA) as protective mechanism [25]. The consequent chronic
suppression of cortisol levels may eventually cause insulin
resistance, which in turn may result in the development of
obesity, hypertension and atherosclerosis; all of which are
implicated in fibroid growth [26].
Hypertension
Evidence suggests that hypertension is involved in the patho-
genesis of fibroids and precedes the development of fibroids
[27]. Hypertension is significantly more likely in women with
fibroids than without, and the risk of fibroid growth increases
with blood pressure, in both users and non-users of hyperten-
sivemedication. For every diastolic increase of 10mmHG, the
risk of fibroid growth increases by 8 and 10 %, respectively
[28, 29]. Faerstein et al. postulated that elevated blood pres-
sure may cause smooth muscle injury and/or secretion of
cytokines similarly to that found in the pathogenesis of
atherosclerosis [28].
Atherosclerosis
Atherosclerosis and uterine fibroids are both smooth muscle,
monoclonal growths which may in part explain their asso-
ciation. High-density lipids (HDLs) which are protective of
atherosclerotic changes are lower in women with fibroids
than in women without, and thicker carotid intima-media
have been shown to be positively associated with uterine
fibroids [28, 30•].
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Obesity
The risk of developing a fibroid is between twofold and three-
fold in obese patients [31]. Elevated BMI and obesity correlate
with patients who have both fibroids and hypertension.
However, obesity does not correlate with the number of
fibroids within the uterus, indicating that in addition to gonad-
otropins, the growth of uterine fibroids may involve other
factors [32–34].
Adipokines and Renin-Aldosterone-Angiotensin System
Both adipokines and the renin-aldosterone-angiotensin system
(RAS) are expressed in the reproductive system, and increase
in expression may be implicated in the pathogenesis of uterine
growths and their recurrence [35–37].
The presence of uterine fibroids is associated with signifi-
cantly decreased levels of the adiponectin [38]. Although
adiponectin is exclusively secreted by adipose tissue, yet its
expression is inversely correlated with body fat. Low
adiponectin levels are implicated in the development of ath-
erosclerosis, obesity and insulin resistance [39].
CAM Therapies for Management of Uterine
Fibroids
Dietary Therapy
Diets related to the pathogenesis of fibroids such as red meats
and high-energy dense foods should be avoided, whereas diets
which prevent fibroid pathogenesis such as flavonoids, oily
fish, green vegetables, citrus fruits, soya and broad beans
should be promoted. These modifications not only have direct
effects on fibroids but on related mechanisms. For example,
hypertension is implicated in pathogenesis and reducing sodi-
um levels can reduce blood pressure. A treatment strategy that
excludes red meat, fat and animal fat, and restricts diet to fruits
vegetables and poultry, and reduces sodium intake can thus
reduce blood pressure and may also exert a protective effect
on fibroid growth [40].
A suggested dietary therapy is outlined in Table 1. Whilst
the recommendations are based on direct and indirect
pathogenesis associations, they have not been subjected
to large-scale trials.
Herbal Medicine
The first record of CHM in gynaecology (the treatment of
fertility) was written in 200 AD. However, the modern con-
struction of a herbal formula is still based on the traditional
criteria insofar as the phytokinetics and dynamics of the herbs
is concerned. Integrating a medical system can prove benefi-
cial to patients, for example, using clomiphene citrate with a
traditional formula to treat anovulatory infertility arising from
polycystic ovarian syndrome (PCOS) can achieve better re-
sults than using either CHM or clomiphene citrate alone [41].
Gui Zhi Fu Ling Tang Ramulus cinnomomi and Poriae
cocos decoction
The most commonly used traditional Chinese medicine
(TCM) formula to treat uterine fibroids is Gui Zhi Fu Ling
Tang (GFLT) [42]. This formula is effective in the treatment of
dysmenorrhea either as a stand-alone treatment or in combi-
nation with progesterone receptor modulator such as mifep-
ristone. The combination GFLT mifepristone therapy was
shown to be more effective than using mifepristone alone
[43•]. Three of the herbs used are known to be anti-
proliferative and are involved in tumour cell apoptosis and
induction of follistatin, Mu Dan Pi (Cortex Moutan), Chi
Shao (Radix Paeoniae Rubra), and Tao Ren (Semen
Persicae) [44–46].
Danshen Gegen decoction (Salviae Miltiorrhizae Radix et
Rhizome and Purariae Lobatae Radix decoction)
The CHM formula Danshen Gegen decoction (DGD) has a
long history of use and recently has been investigated for its
anti-atherosclerotic effects. Investigative results into DGD
indicate that it positively modulates key early events in ath-
erosclerosis [47–49]. The main active components in Danshen
and Gegen, tanshinones and genistein, respectively, are most
likely responsible for the effects of DGD, although other
factors in the formula may also be involved.
Genistein
The isoflavone genistein has a number of properties involved
in the inhibition atherosclerosis. Genistein is an anti-
inflammatory and modulates vascular inflammation [50].
Genistein also inhibits tyrosine kinases, enzymes involved in
cellular growth and proliferation signal cascade; blocks plate-
let aggregation; and modulates genes related to cell cycle and
apoptosis [51]. In addition, genistein also modulates nuclear
factor-kappa B (NFkB). As a result, genistein may also be able
to mediate uterine fibroid growth [52].
Tanshinones
The flavonoid tanshinone IIA is derived from Danshen
(Salviae Miltiorrhizae Radix et Rhizome), a herb used in the
treatment of hypertension, cardiovascular disease and hyper-
tension, cancer and liver damage [53].
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Tanshinone IIA attenuates atherosclerosis [54]. Its effects
include downregulation of adhesion molecules, improvement
of microcirculation by inducing endothelium-dependent vaso-
dilatation in coronary arterioles through a range of
neuromodulators including endothelial nitric oxide synthase
(eNOS) and angiotensin II [55, 56]. Interestingly, it also in-
hibits vascular smooth muscle cell proliferation and decreases
intimal thickening through mechanisms involvingMAPK sig-
nalling pathway [57].
Green Tea (Camellia sinensis)
Twenty-five percent of green tea is comprised of the flavanols
and catechins, and epigallocatechin-3-gallate (EGCG) is
extracted from this group. A small randomised controlled trial
(n=39) found that the flavanol EGCG significantly reduced
volume of uterine fibroids and improved symptoms of anae-
mia and blood loss [58•].
The reduction of fibroid volume is attributed in part to the
inhibitory action of EGCG on catechol-O-methyltransferase
(COMT). In comparison to surrounding myometrial tissue,
COMT is elevated in uterine fibroids and involved in their
pathogenesis [59]. A common genetic variation of COMT is
also implicated in cardiovascular disease and high blood pres-
sure [60, 61]. Furthermore, a reduction of atherosclerotic le-
sions induced by COMT in animals implies a relationship
between EGCG and COMT in the treatment of this disease
in humans [62].
Table 1 Dietary therapy and
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Mackerel Vitamin C Regular exercise






















Unsweetened fruit juice Sweetened juice
Milk (semi-skinned) High-sugar drinks
a Not to be consumed by people with the hereditable condition of Favism
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Acupuncture
TCM is a system of medicine with several therapies, of which
TCM acupuncture is the most popular in literature. In the
1950s, electro-acupuncture was introduced to TCM. There is
an abundance of evidence that acupuncture modulates a wide
range of endocrinological, neurohormonal, immunological,
paracrine and autocrine factors [63–65].
Acupuncture acts on a variety of therapeutic targets asso-
ciated in the pathogenesis and symptomatology of fibroids. It
is effective treatment for dysfunctional bleeding and chronic
pelvic inflammatory disease and dysmenorrhoea [66–68] (see
Table 2 for acupuncture points used in the treatment of heavy
periods).
Stener-Victorin suggested that stimulation of afferent nerve
fibres may be one of the mechanisms that acupuncture exerts
its effects. Such stimulation would inhibit sympathetic out-
flow at the spinal level. Furthermore, acupuncture also causes
secretion of sensory neurotransmitters, such as substance P
and calcitonin gene-related peptide (CGRP), which may effect
neuronal transmission. Nerve impulses (action potentials) usu-
ally travel away from the nerve cell body, along the axon, to
the axon terminals, from which the impulses are conveyed (to
a subsequent neuron). This usual direction of travel is termed
orthodromic. However, because acupuncture induces the se-
cretion of sensory neuromodulators, an effect of acupuncture
may induce nerve impulses to travel in the opposite direction,
that is, away from the axon terminals towards the cell body.
This opposite direction of travel is termed anti-dromic and
may be another mechanism by which acupuncture modulates
the central nervous system [71, 72] (see Fig. 1).
Whether these effects seen in mixed populations translates
into improvements in bleeding and pain symptoms associated
with fibroids per se remains to be seen.
Acupuncture treatments are effective in improving outcomes
in overweight and obese patients. Results from animal experi-
ments have found that acupuncture treatments reduce appetite
and affect satiety at the level of the hypothalamus, thus impli-
cating a role of energy homeostasis neurohormones such as
leptin in the management of appetite by acupuncture [73].
This effect may also be a result of the pro-inflammatory cyto-
kine downregulation involved in acupuncture treatments [74].
Both manual acupuncture and low-frequency electro-
acupuncture (LFEA) can lower leptin and raise adiponectin
secretion [75, 76].
Acupuncture and Infertility
The role of fibroids in causation of infertility is controversial.
Fibroids in certain locations and sizes have been shown to
lower success rates. On the other hand, irrespective of cause,
infertility and its treatments result in significant stress and
anxiety to patients. Women are more likely to experience guilt
and hostility than fertile women, and treatment can lead to
clinical anxiety and depression [77].
Table 2 Acupuncture points:
heavy periods Acupuncture points for heavy periods resulting from blood stasis
Channel name and number Pinyin Actions associated with traditional
use
Gall bladder 34 Yang Ling Quan Moves blood
Ren 6 Qihai Moves blood
Spleen 10 Xuehai Invigorates blood
Bladder 17 Geshu Invigorates blood
Stomach 29 Guilai Invigorates blood in the lower
abdomen
Liver 3 Taichong Invigorates liver blood
Spleen 6 Sanyinjiao Invigorates liver blood
Liver 8 Qu Quan Nourishes blood
Stomach 36 Zusanli Nourishes blood
Bladder 20 Pishu Nourishes blood





Maciocia [69] and Deadman et al. [70]
Fig. 1 Nerve impulses (also known as an action potentials) usually travel
from the cell body to the axon terminals (orthodromic). In some cases,
nerve impulses travel from the axon terminals towards the cell body
(antidromic)
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Fertility-related stress may also negatively affect IVF treat-
ment [78•]. Trials have also shown that acupuncture signifi-
cantly alleviates depression, anxiety and stress by modulating
both specific and non-specific neurological signalling and also
neuromodulators such as cortisol, prolactin, epinephrine and
beta endorphin [79, 80].
The effect of acupuncture treatments for IVF/ICSI has been
examined during the last decade. Whilst some trials have
found significant increases in clinical pregnancy and live birth
rates when acupuncture is integrated with IVF, the results of
meta-analyses are inconclusive due to methodological differ-
ences and heterogeneity of populations studied [81–84]. In
addition, placebo acupuncture may not be inert, which may
explain some of the differences between placebo-controlled
trials involving acupuncture [85].
Avariety of mechanisms have been proposed to explain the
anti-fertility effects of uterine fibroids. Of particular interest to
CAM is an increase in myometrial contractility observed with
fibroids during implantation and increase in conception rates
following myomectomy in women with two or more peristal-
tic movements in 3 min [86].
A potential candidate marker for effectiveness of acupunc-
ture therapy is the vasoactive modulator, CGRP, which is
upregulated during the window of implantation [87]. CGRP
inhibits angiotensin II and relaxes smooth muscle in the uterus
[88].Modulation of CGRP by acupuncture may inhibit uterine
contractions associated with fibroids, and a trial investigating
this is underway at our centre.
Suggested Approach to the Management of Uterine
Fibroids
An integrated approach using both CM and CAM is essential
in providing holistic and safe and effective treatment [89, 90].
Following referral, a detailed history is taken including life-
style, diet, family history, and signs and symptoms relating to
TCM. The results of any previous investigations and treat-
ments including CM are also reviewed. It is best practice that
the diagnosis of fibroids is established using conventional
medicine.
Therapeutic options depend on the outcome of consulta-
tion, investigations, interdisciplinary discussions and patient
choice. CAM treatment may involve herbal, acupuncture and
dietary/lifestyle choices. Insofar as CAM treatments are se-
lected, CHM is the treatment of choice to reduce volume of
uterine fibroids, and, for management of chronic conditions,
whereas acupuncture is more efficient in the management of
acute conditions, probably due to its modulation of neurohor-
mones such as beta endorphins, leptin and other biochemicals.
The increased frequency of acupuncture treatments potenti-
ates the effects of acupuncture, and so, the therapy can also
be used in the treatment of chronic conditions.
During the course of treatments, other problems may arise
and it is important to treat what is presented by the patient at
that time.
Conclusion
A variety of CAM therapies are available, and there is an
urgent need to subject them to academic rigour. A clear un-
derstanding of underlying mechanistic pathways and patient’s
symptoms and needs is crucial in planning individualised ther-
apies. An integrated CM CAM model is likely to yield better
patient outcomes and reduced health care costs.
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